Navigation Links
New study announced that will use genetics to test for Alzheimer's risk
Date:7/19/2012

Boston, MA In a new Alzheimer's disease risk assessment study unveiled this week during the Alzheimer's Association International Conference, researchers at Brigham and Women's Hospital (BWH) are offering genetic testing and Alzheimer's risk estimates for people who are experiencing mild cognitive impairment.

The Risk Evaluation and Education for Alzheimer's Disease Study (REVEAL) is a multi-center randomized controlled trial funded by the National Institutes of Health and led by Robert C. Green, MD, MPH, a physician-scientist in the Division of Genetics at BWH.

"We are on the brink of developing disease modifying treatments and preventative measures to combat Alzheimer's disease," Green said. "As health professionals begin to put these discoveries into medical practice, they will need to communicate complex risk information to individuals and their families. We expect that the REVEAL study will provide accurate guidance for estimating and communicating risk information to individuals, and we hope that results from REVEAL will inform the future practice of treating individuals at risk for Alzheimer's disease."

The goal of the REVEAL study is to determine how people with mild cognitive impairment and their caregivers respond to health education and genetic testing. Researchers will evaluate how well participants understand the Alzheimer's risk assessment materials and the implications of the genetic test. After the results are returned to the participants, researchers will monitor how participants adjust psychologically and what behavioral changes they make in response to the new information.

Mild cognitive impairment is a common condition where those affected have noticeable memory and thinking problems but can still carry out their usual activities. People with mild cognitive impairment are at elevated risk for developing Alzheimer's disease, so it is important to evaluate the different methods of providing risk information for Alzheimer's, including genetic testing, to those individuals and their loved ones. REVEAL participants will have the opportunity to learn what it means to have mild cognitive impairment, what their chances are of developing Alzheimer's and how to cope with problems related to memory loss. Researchers will follow up with participants for a period of six months after the risk assessment is received.


'/>"/>

Contact: Tom Langford
tlangford@partners.org
617-534-1605
Brigham and Women's Hospital
Source:Eurekalert

Related biology news :

1. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
2. Law that regulates shark fishery is too liberal: UBC study
3. New study will help protect vulnerable birds from impacts of climate change
4. Study jointly led by UCSB researcher supports theory of extraterrestrial impact
5. BYU study: Using a gun in bear encounters doesnt make you safer
6. 15-year study: When it comes to creating wetlands, Mother Nature is in charge
7. Pycnogenol (French maritime pine bark extract) shown to improve menopause symptoms in new study
8. Crystal structure of archael chromatin clarified in new study
9. EU-funded study underlines importance of Congo Basin for global climate and biodiversity
10. University of Houston study shows BP oil spill hurt marshes, but recovery possible
11. Study demonstrates cells can acquire new functions through transcriptional regulatory network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... -- Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the ... latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Display- Ampronix News ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of ... higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... of the cuvette holder. , FireflySci has developed several Agilent flow cell product ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... announce the launch of their brand, UP4™ Probiotics, into Target stores nationwide. The ... is proud to add Target to its list of well-respected retailers. This list ...
(Date:6/23/2016)... , June 23, 2016 A person commits a ... crime scene to track the criminal down. An ... Food and Drug Administration (FDA) uses DNA evidence to track ... Sound far-fetched? It,s not. The FDA has increasingly ... support investigations of foodborne illnesses. Put as simply as possible, ...
(Date:6/23/2016)... 2016  The Prostate Cancer Foundation (PCF) is pleased to announce ... cures for prostate cancer. Members of the Class of 2016 were selected from ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology: